ArticleResearch and practice in thrombosis and haemostasis2025

Relevance of anti-platelet factor 4/heparin antibodies and platelet activation in systemic inflammatory diseases and thrombosis disorders: insight from the COVID-19 pandemic.

Nicolas Gendron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.